Description
Tesamorelin Peptide | 5mg Vial
Tesamorelin 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.
Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device. Not for diagnostic or therapeutic use on this page. Must not be administered to people or animals.
Authorised tesamorelin medicines exist in some countries as prescription-only products. This vial is not those products and is not offered as a substitute.
Identification
| Product name | Tesamorelin |
| Research description | N-acylated GHRH(1–44) analogue (trans-3-hexenoyl-GHRH(1–44)-NH₂) |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| CAS | 218949-48-5 |
| Approx. mass | ~5136 Da |
| Class | Synthetic peptide / GHRH analogue (research ligand) |
| Intended use | Laboratory / in-vitro research only |
Not sermorelin, CJC-1295, or tesamorelin drug-product pens.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
Tesamorelin is a stabilised analogue of growth hormone-releasing hormone (GHRH 1–44) used in literature as a GHRH-receptor research ligand. Peer-reviewed clinical programmes later supported a licensed indication in selected markets for a defined prescription use. Those authorisations apply only to approved drug products. They do not apply to this research vial and must not be rewritten as fat-loss or body-composition claims.
GHRH analogues may fall under WADA peptide-hormone restrictions in sport. That is an anti-doping listing, not a use instruction.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.






Reviews
There are no reviews yet.